A patient with a diagnosis of acute paranoid schizophrenia was referred to PDAN while an involuntary psychiatric inpatient. One of the conditions for his release back into the community was taking his psychiatric medications as prescribed. While he had Medicare prescription drug coverage, the primary medication he needed carried a co-pay of $750.00 for a one month supply which he could not afford. We were able to get the injectable medication for free from a national pharmaceutical company. With the medication, the patient was discharged from expensive inpatient hospitalization to a self-funded supervised community setting.